In this study, 12 asymmetric
curcumin (CUR) analogues and 5 symmetric
curcumin derivatives were synthesized, the
antioxidant activity of these derivatives were evaluated by radicals 1,1-diphenyl-2-picryl-hydrazyl (DPPH) assay, 2,2-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (
ABTS) assay, ROO (TRAP) assay and O(2-) (NET) assay and anti-proliferative activities of these analogues were assessed against the human
hepatoma cell line (SMMC-7721), the human
breast cancer cell line (MCF-7) and the human
prostate cancer cell lines (PC-3). Most of the asymmetric compounds showed stronger
antioxidant activities than
Vitamin C (Vc).
Curcumin analogues reducing
free radicals contain two reaction mechanisms: H-atom and electron transfer mechanisms. Compound 14 showed the most significant
antioxidant activity compared with
curcumin and other derivatives. Shorted the
carbon chain of 14 can reduce the O-H bond dissociation enthalpy (BED) to improve the
antioxidant activity. The
antioxidant activity of 25 was similar to
curcumin. All of the compounds performed better in an anti-proliferate assay than
curcumin, especially compound 25, which exhibited the preferential cytotoxic activity against MCF-7 cells(25, IC50 = 9.11 μM,
curcumin, IC50 = 70.2 μM). Considering these data, future studies should be performed to assess the therapeutic values of these asymmetric
curcumin analogues.